Guy Van Lommen

659 total citations
25 papers, 530 citations indexed

About

Guy Van Lommen is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Guy Van Lommen has authored 25 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 5 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Guy Van Lommen's work include Synthesis and Reactivity of Heterocycles (5 papers), Synthesis and Biological Evaluation (4 papers) and Chemical Synthesis and Analysis (3 papers). Guy Van Lommen is often cited by papers focused on Synthesis and Reactivity of Heterocycles (5 papers), Synthesis and Biological Evaluation (4 papers) and Chemical Synthesis and Analysis (3 papers). Guy Van Lommen collaborates with scholars based in Belgium, United States and Poland. Guy Van Lommen's co-authors include J.E. Leysen, Piet Herdewijn, W Gommeren, Petrus J. Pauwels, Paul A. J. Janssen, Omprakash Bande, Mieke Buntinx, J. Van Wauwe, Patricia A. Janssen and H.P. Figeys and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

In The Last Decade

Guy Van Lommen

25 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guy Van Lommen Belgium 14 237 157 88 53 45 25 530
Elena Carceller Spain 18 374 1.6× 283 1.8× 53 0.6× 27 0.5× 55 1.2× 42 828
Michel Perez France 14 281 1.2× 403 2.6× 109 1.2× 53 1.0× 65 1.4× 34 759
Aldo Balsamo Italy 18 358 1.5× 258 1.6× 148 1.7× 46 0.9× 16 0.4× 56 747
John E. Tellew United States 14 322 1.4× 280 1.8× 81 0.9× 28 0.5× 32 0.7× 22 669
Raj N. Misra United States 19 525 2.2× 287 1.8× 130 1.5× 45 0.8× 14 0.3× 37 924
Steven A. Boyd United States 18 320 1.4× 322 2.1× 45 0.5× 71 1.3× 18 0.4× 34 739
Ligaya M. Simpkins United States 13 229 1.0× 324 2.1× 75 0.9× 25 0.5× 15 0.3× 16 545
Joseph B. Santella United States 11 567 2.4× 312 2.0× 88 1.0× 92 1.7× 86 1.9× 19 901
Roberta Tesch Germany 14 217 0.9× 263 1.7× 76 0.9× 37 0.7× 28 0.6× 20 520
Christopher J. Rito United States 11 178 0.8× 428 2.7× 44 0.5× 22 0.4× 22 0.5× 13 621

Countries citing papers authored by Guy Van Lommen

Since Specialization
Citations

This map shows the geographic impact of Guy Van Lommen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Van Lommen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Van Lommen more than expected).

Fields of papers citing papers by Guy Van Lommen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Van Lommen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Van Lommen. The network helps show where Guy Van Lommen may publish in the future.

Co-authorship network of co-authors of Guy Van Lommen

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Van Lommen. A scholar is included among the top collaborators of Guy Van Lommen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Van Lommen. Guy Van Lommen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wouters, Johan, et al.. (2018). Regio‐ and Diastereoselective Functionalization of 3‐Amino‐hexahydrooxazoninones. European Journal of Organic Chemistry. 2019(1). 36–40. 3 indexed citations
2.
Lommen, Guy Van, et al.. (2015). Synthesis and Selective N,O‐Functionalization of Pyrazolone‐Fused 3‐Aminoazepinones. European Journal of Organic Chemistry. 2015(16). 3572–3576. 2 indexed citations
3.
Urbańczyk-Lipkowska, Z., Dirk Tourwé, Steven Ballet, et al.. (2014). Synthesis of Fused 3-Aminoazepinones via Trapping of a New Class of Cyclic Seven-Membered Allenamides with Furan. Organic Letters. 16(14). 3712–3715. 18 indexed citations
4.
Bande, Omprakash, et al.. (2014). Organophosphorus-catalyzed diaza-Wittig reaction: application to the synthesis of pyridazines. Organic & Biomolecular Chemistry. 12(36). 7159–7166. 25 indexed citations
5.
Bande, Omprakash, et al.. (2013). A novel and convenient strategy for the synthesis of phthalazines from an aryne precursor. Tetrahedron Letters. 54(51). 7056–7058. 10 indexed citations
7.
Lommen, Guy Van, et al.. (2012). A short and convenient strategy for the synthesis of pyridazines via Diaza–Wittig reaction. Tetrahedron Letters. 53(48). 6489–6491. 15 indexed citations
8.
Barbay, J. Kent, Yong Gong, Mieke Buntinx, et al.. (2008). Synthesis and characterization of 5,6,7,8-tetrahydroquinoline C5a receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(8). 2544–2548. 24 indexed citations
10.
Gong, Yong, J. Kent Barbay, Mieke Buntinx, et al.. (2008). Design and optimization of aniline-substituted tetrahydroquinoline C5a receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(14). 3852–3855. 13 indexed citations
11.
Buntinx, Mieke, et al.. (2008). Synthesis and structure–activity relationship of benzetimide derivatives as human CXCR3 antagonists. Bioorganic & Medicinal Chemistry Letters. 18(21). 5819–5823. 15 indexed citations
12.
Doyon, Julien, Mieke Buntinx, Bart Hermans, et al.. (2008). Discovery of Potent, Orally Bioavailable Small‐Molecule Inhibitors of the Human CCR2 Receptor. ChemMedChem. 3(4). 660–669. 13 indexed citations
13.
Herrebout, Wouter, Benjamin van der Veken, Alex De Groot, et al.. (2006). Elucidation of the absolute configuration of JNJ‐27553292, a CCR2 receptor antagonist, by vibrational circular dichroism analysis of two precursors. Chirality. 18(8). 609–620. 7 indexed citations
14.
Lommen, Guy Van, et al.. (1996). ChemInform Abstract: Discovery of a Series of New Non‐Indole 5HT1D Agonists. ChemInform. 27(12). 1 indexed citations
15.
Lommen, Guy Van, et al.. (1995). The discovery of a series of new non-indole 5HT1D agonists. Bioorganic & Medicinal Chemistry Letters. 5(22). 2649–2654. 18 indexed citations
16.
Leysen, J.E., Petrus J. Pauwels, W Gommeren, Guy Van Lommen, & Patricia A. Janssen. (1991). The Receptor Binding Profile of the New Antihypertensive Agent Nebivolol and its Stereoisomers Compared with Various β-Adrenergic Blockers. Clinical Drug Investigation. 3(S1). 120–121. 34 indexed citations
17.
Lommen, Guy Van, et al.. (1991). Synthesis and pharmacological properties of nebivolol, a new antihypertensive compound.. PubMed. 45(6). 355–60. 6 indexed citations
18.
Pauwels, Petrus J., W Gommeren, Guy Van Lommen, Paul A. J. Janssen, & J.E. Leysen. (1988). The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.. Molecular Pharmacology. 34(6). 843–851. 92 indexed citations
19.
Figeys, H.P., et al.. (1980). Synthesis and rearrangements of alkyl-quadricyclanones. Tetrahedron Letters. 21(24). 2369–2372. 2 indexed citations
20.
Figeys, H.P., et al.. (1980). Olefinic and acetylenic compounds.v. the regiospecific synthesis of 1,5- disubstituted-cyclooctatetraene derivatives.. Tetrahedron Letters. 21(24). 2365–2368. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026